The evolution of resistant Candida species in cancer centers: implications for treatment and prophylaxis.
Riddell
James
J
Kauffman
Carol A
CA
D000935:Antifungal Agents / Q000627:therapeutic use; D002173:Cancer Care Facilities; D002175:Candida / Q000145:classification / Q000472:pathogenicity*; D002177:Candidiasis / Q000188:drug therapy / Q000382:microbiology*; D025141:Drug Resistance, Fungal; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000382:microbiology*
D000935:Antifungal Agents